Search clinical trials for: Cutaneous Squamous Cell Carcinoma

Total 64722 results

International BFM Study Group
European Organisation for Research and Treatment of Cancer - EORTC; Associazione... and other collaborators

Completed

Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia

Germany, Argentina, Austria, Belgium, Chile, Czech Republic, Hungary, Italy
AZ-VUB
Fund for Scientific Research, Flanders, Belgium; Belgian Government

Terminated

Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts

Type 1 Diabetes | Islet Transplantation

Belgium
Shaare Zedek Medical Center

Unknown

Sensitivity and Specificity of Color Doppler Directed Temporal Artery Biopsy as Compared to Standard Random Biopsy in the Diagnosis of Temporal Arteritis

Temporal Arteritis | Duplex of Temporal Artery | Biopsy of Temporal Artery

Israel
Ludwig-Maximilians - University of Munich

Unknown

Melanoma Inhibitory Activity (MIA): A Serological Marker for Metastatic Uveal Melanoma

Melanoma | Radiotherapy | Metastatic Disease

Germany
Medical University of Graz

Completed

Telmisartan and Losartan in Hypertensive IGT

Hypertension | Impaired Glucose Tolerance

Austria
University of Turin, Italy

Completed

Melphalan, Prednisone, Thalidomide And Bortezomib In Advanced And Refractory Multiple Myeloma Patients

Multiple Myeloma

Italy
Alexion Pharmaceuticals

Completed

Study Using Eculizumab in Transfusion Dependent Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients

Hemoglobinuria, Paroxysmal

United States, Australia, Belgium, Canada, Germany, Italy, United Kingdom, France, Ireland, Netherlands, Sweden, Switzerland
Johann Wolfgang Goethe University Hospital

Terminated

Cell Therapy for Coronary Heart Disease

Coronary Artery Disease

Germany
University of Turin, Italy

Completed

Melphalan, Prednisone, and CC-5013 (Revlimid) as Induction Therapy in Multiple Myeloma

Multiple Myeloma

Italy
UMC Utrecht
Dutch Health Care Insurance Board

Completed

Prevention of Glucocorticoid-Induced Osteoporosis in Rheumatic Diseases: Alendronate Versus Alfacalcidol.

Rheumatoid Arthritis | Polymyositis | Giant Cell Arteritis | Polymyalgia Rheumatica | Wegener's Granulomatosis

Netherlands
National Institute of Cancerología
National Council of Science and Technology, Mexico; Psicofarma S.A. de C.V.

Completed

Hydralazine and Valproate Plus Cisplatin Chemoradiation in Cervical Cancer

Cervical Cancer

Mexico
National Institute of Cancerología
National Council of Science and Technology, Mexico; Psicofarma S.A. de C.V.

Completed

A Phase II Study of Epigenetic Therapy to Overcome Chemotherapy Resistance in Refractory Solid Tumors

Refractory Solid Tumors

Mexico
Xcyte Therapies

Completed

Autologous T Cell Immunotherapy for Chronic Lymphocytic Leukemia (CLL) Patients

Chronic Lymphocytic Leukemia

United States
National Institute of Cancerología

Unknown

DHPLC Determination of TPMT Polymorphisms.

Acute Lymphoblastic Leukemia

Mexico
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...

Completed

CD133+ Autologous Cells After Myocardial Infarction

Acute Myocardial Infarction

Italy
Brazilan Center for Studies in Dermatology

Completed

Evaluation of the Efficacy of Endermologie in Treatment of Cellulite and Body Contouring

Cellulite | Body Contouring
AGO Study Group

Completed

Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian Cancer

Ovarian Cancer
International Vaccine Institute
Göteborg University; National Institute of Hygiene and Epidemiology, Vietnam

Completed

Safety and Immunogenicity of a New Formulation of a Bivalent Killed, Whole-Cell Oral Cholera Vaccine

Cholera

Vietnam
Pfizer

Completed

Safety and Efficacy of (PN-152,243)/PN-196,444 in the Prevention of Thrombocytopenia

Neoplasms | Multiple Myeloma | Lymphoma, Malignant | Thrombocytopenia

United States, Argentina, Mexico
AGO Study Group

Completed

Randomized, Multicenter, 2-Dose Level. Open-Label, Phase IIa Study With the Intraperitoneally Infused Trifunctional Bispecific Antibody Removab(TM) (Anti-EpCAM x Anti-CD3) to Select the Better Dose Level in Platinum Refractory Epithelial Ovarian Cancer Patients

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer

Germany
Pfizer

Completed

A Phase 2, Randomized, Open-Label Study Of Single Agent CI-1033 In Patients With Advanced Non-Small Cell Lung Cancer

Lung Neoplasms

United States, Canada, Ireland, United Kingdom, Italy, Germany, Spain, Netherlands
Morton Plant Mease Health Care
Ortho Biotech Products, L.P.

Terminated

Liposomal Doxorubicin and Estramustine Phosphate: Study in Taxane Resistant, Hormone Refractory Advanced Prostate Cancer

Prostate Cancer

United States
Xcyte Therapies

Unknown

T Cell Immunotherapy for Multiple Myeloma Patients Undergoing a Bone Marrow Transplant

Multiple Myeloma

United States
National Institute of Cancerología
National Council of Science and Technology, Mexico; Psicofarma S.A. de C.V.

Terminated

Hydralazine and Valproate Added to Chemotherapy for Breast Cancer

Locally Advanced Breast Cancer

Mexico
University of Ottawa
Canadian Institutes of Health Research (CIHR)

Unknown

Stem Cell Mobilization by G-CSF Post Myocardial Infarction to Promote Myocyte Repair

Myocardial Infarction

Canada
Tel-Aviv Sourasky Medical Center
Radiation Therapy Oncology Group

Unknown

URINARY VEGF Levels in GBM Patients on Radiation Treatment Protocol

Glioblastoma

Israel
University of Trieste

Unknown

Avastin for CNV Secondary to Pattern Dystrophy

Choroidal Neovascularization Secondary to Pattern Dystrophy

Italy
TheraVitae Ltd.
Mahidol University

Unknown

EPC by Intracoronary Injection in Patients With Chronic Stable Angina

Coronary Artery Disease

Israel
Charles University, Czech Republic

Unknown

Intracoronary Stem Cells in Large Myocardial Infarction

Myocardial Infarction
Medical University of Vienna

Unknown

Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell Lymphoma

Lymphoma, Mantle-Cell

Austria
Royal Marsden NHS Foundation Trust

Completed

A Randomized Trial of Human Growth Hormone (hGH) vs Placebo in Intensively Treated Haemato-Oncology Patients.

Acute Myeloid Leukemia | Multiple Myeloma | Acute Lymphoblastic Leukemia | Myelodysplastic Syndrome
University of Connecticut
Janssen Pharmaceutica N.V., Belgium

Terminated

Haloperidol vs. Risperidone in the Treatment of Aggression in Psychotic Inmates

Aggression | Psychosis

United States
University Hospital Freiburg
Novartis; German Federal Ministry of Education and Research; Deutsche Krebshilfe...

Completed

Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Germany
GammaCan

Unknown

IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma

Malignant Melanoma | Urologic Cancer | Cancer of Colon

Israel
Hospital Clinic of Barcelona

Terminated

Immune Reconstitution in naïve HIV Patients With CD4 <100 Cells/mL When Treated With Lopinavir or Efavirenz.

HIV Infection

Spain
Bayside Health

Unknown

Atorvastatin in Myeloma

Myeloma

Australia
University of Magdeburg

Unknown

Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL

Lymphoma, High-Grade

Germany
University of Magdeburg

Unknown

Risk Adapted Therapy Optimization for Patients With Relapsed or Refractory Aggressive Non-Hodgkin-Lymphoma

Non-Hodgkin's Lymphoma

Germany
Bayside Health

Unknown

The Role of Naive T-Cells in HIV Pathogenesis

HIV Infections

Australia
AGO Study Group

Completed

Use of ACA 125 in Patients With Ovarian Cancer: Safety and Immune Response

Fallopian Tube Neoplasms | Peritoneal Neoplasms | Ovarian Cancer

Germany
Nordic Myeloma Study Group

Unknown

Fludarabine Added to Induction Treatment in Untreated Multiple Myeloma Patients

Multiple Myeloma

Denmark
The Alvin and Lois Lapidus Cancer Institute
Ortho Biotech Products, L.P.

Unknown

A Dose Study of Doxil in a Dose Dense, 14 Day CDOP/Rituximab Regimen for Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NHL)> 60 Years or With Compromised Cardiac Status.

Lymphoma, Non-Hodgkin | Diffuse Large B Cell Lymphoma

United States
Korean Multiple Myeloma Working Party
Janssen-Cilag Ltd.

Unknown

Sequential VAD and VTD Followed by HDT With ASCT and Velcade Maintenance for NDMM

Multiple Myeloma

Korea, Republic of
University of Bologna

Completed

Autologous Transplantation for Multiple Myeloma

Multiple Myeloma
Austrian Breast & Colorectal Cancer Study Group
Pharmacia Austria GmbH

Completed

Neoadjuvant Endocrinotherapy of Breast Cancer (Mamma Carcinoma) With Exemestane

Breast Cancer

Austria
Cytos Biotechnology AG

Completed

Safety and Immunogenicity of a Melan-A VLP Vaccine in Advanced Stage Melanoma Patients

Malignant Melanoma

Switzerland
Eli Lilly and Company

Terminated

Gemzar (Gemcitabine) and Alimta (Pemetrexed) in the Treatment of Patients With Recurrent Platinum-Sensitive and Platinum-Resistant Ovarian or Peritoneal Cancer

Ovarian Cancer | Peritoneal Cancer

United States
Weill Medical College of Cornell University

Terminated

Weekly Topotecan Therapy in Patients With Ovarian Cancer

Ovarian Cancer

United States
University of Michigan Rogel Cancer Center
University of Michigan

Terminated

Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine

Metastatic Colorectal Cancer

United States
Gustave Roussy, Cancer Campus, Grand Paris
Hoffmann-La Roche

Terminated

Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALL

Burkitt Lymphoma

France

Search clinical trials for: Cutaneous Squamous Cell Carcinoma

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Vietnam

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations